LASER and Radiofrequency and Genitourinary Syndrome of Menopause

NAActive, not recruitingINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Postmenopausal Atrophic VaginitisPostmenopausal SymptomsGenitourinary Symptoms
Interventions
PROCEDURE

LASER

Use of the SmartXide Touch V²LR, Co2 Laser System to perform ambulatory intravaginal and vulvar application of LASER, to postmenopausal genitourinary syndrome. The patient will be in gynecological position, after remove of vaginal secretion, with gauze and under topic anesthesia, the LASER will be applied, according to the protocol of the manufactured.

PROCEDURE

Microablative Radiofrequency

Use of Linly™ equipment to perform ambulatory intravaginal and vulvar application of fractionated microablative radiofrequency, to postmenopausal genitourinary syndrome. The patient will be in gynecological position, after remove of vaginal secretion, with gauze and under topic anesthesia, the radiofrequency will be applied, according to the protocol of the manufactured.

DRUG

Estriol

The patient will perform self application of this vaginal estriol daily for 2 weeks and after that the applications will occur twice a week.

Trial Locations (1)

0-4023- 062

Federal University of Sao Paulo - Unifesp, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

Federal University of São Paulo

OTHER

NCT04045379 - LASER and Radiofrequency and Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter